Paradigm Biopharmaceuticals’s (PAR) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Paradigm Biopharmaceuticals is a Buy.
Paradigm Biopharmaceuticals’s (PAR) 20-Day exponential moving average is 0.24, while Paradigm Biopharmaceuticals’s (PAR) share price is AU$0.25, making it a Buy.
Paradigm Biopharmaceuticals’s (PAR) 50-Day exponential moving average is 0.24, while Paradigm Biopharmaceuticals’s (PAR) share price is AU$0.25, making it a Buy.
Paradigm Biopharmaceuticals’s (PAR) 10-Day exponential moving average is 0.25, while Paradigm Biopharmaceuticals’s (PAR) share price is AU$0.25, making it a Sell.
Paradigm Biopharmaceuticals’s (PAR) 100-Day exponential moving average is 0.23, while Paradigm Biopharmaceuticals’s (PAR) share price is AU$0.25, making it a Buy.
Paradigm Biopharmaceuticals’s (PAR) stock price is AU$0.25 and Paradigm Biopharmaceuticals’s (PAR) 50-day simple moving average is 0.25, creating a Sell signal.
Paradigm Biopharmaceuticals’s (PAR) stock price is AU$0.25 and Paradigm Biopharmaceuticals’s (PAR) 100-day simple moving average is 0.21, creating a Buy signal.
Paradigm Biopharmaceuticals’s (PAR) stock price is AU$0.25 and Paradigm Biopharmaceuticals’s (PAR) 200-day simple moving average is 0.22, creating a Buy signal.